The NLRP3 inflammasome triggers sterile neuroinflammation and Alzheimer's disease.

[1]  C. Pellegrini,et al.  Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications? , 2020, Progress in Neurobiology.

[2]  M. Heneka,et al.  β-Amyloid Clustering around ASC Fibrils Boosts Its Toxicity in Microglia , 2020, Cell reports.

[3]  Y. Hao,et al.  New mechanism of neuroinflammation in Alzheimer's disease: The activation of NLRP3 inflammasome mediated by gut microbiota , 2020, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[4]  M. Heneka,et al.  Soluble Aβ oligomers and protofibrils induce NLRP3 inflammasome activation in microglia , 2019, Journal of neurochemistry.

[5]  L. Buée,et al.  NLRP3 inflammasome activation drives tau pathology , 2019, Nature.

[6]  K. Schroder,et al.  Inflammasome signaling and regulation of interleukin-1 family cytokines , 2019, The Journal of experimental medicine.

[7]  M. Heneka,et al.  Systemic inflammation impairs microglial Aβ clearance through NLRP3 inflammasome , 2019, The EMBO journal.

[8]  C. Day,et al.  MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition , 2019, Nature Chemical Biology.

[9]  J. Ting,et al.  The NLRP3 inflammasome: molecular activation and regulation to therapeutics , 2019, Nature Reviews Immunology.

[10]  I. Dewachter,et al.  Aggregated Tau activates NLRP3–ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo , 2019, Acta Neuropathologica.

[11]  Dan J Stein,et al.  Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2019, The Lancet Neurology.

[12]  A. Angiolillo,et al.  Circulating levels of IL-1 family cytokines and receptors in Alzheimer’s disease: new markers of disease progression? , 2018, Journal of Neuroinflammation.

[13]  Zhijian J. Chen,et al.  PtdIns4P on Dispersed Trans-Golgi Network Mediates NLRP3 Inflammasome Activation , 2018, Nature.

[14]  Daniel R. Caffrey,et al.  Inflammasome-derived cytokine IL18 suppresses amyloid-induced seizures in Alzheimer-prone mice , 2018, Proceedings of the National Academy of Sciences.

[15]  K. Schroder,et al.  Interleukin-1β Maturation Triggers Its Relocation to the Plasma Membrane for Gasdermin-D-Dependent and -Independent Secretion. , 2018, Cell reports.

[16]  B. Delatour,et al.  New role of P2X7 receptor in an Alzheimer’s disease mouse model , 2018, Molecular Psychiatry.

[17]  L. Facci,et al.  Serum amyloid A primes microglia for ATP-dependent interleukin-1β release , 2018, Journal of Neuroinflammation.

[18]  Justyna O. Ekert,et al.  TNF alpha inhibitors in Alzheimer's disease: A systematic review , 2018, International journal of geriatric psychiatry.

[19]  M. Surette,et al.  Age-Associated Microbial Dysbiosis Promotes Intestinal Permeability, Systemic Inflammation, and Macrophage Dysfunction , 2018, Cell host & microbe.

[20]  D. Gibson,et al.  Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines , 2018, Front. Immunol..

[21]  Jelena S. Bezbradica,et al.  Caspase-1 self-cleavage is an intrinsic mechanism to terminate inflammasome activity , 2018, The Journal of experimental medicine.

[22]  L. Hooper,et al.  Dysbiosis-Associated Change in Host Metabolism Generates Lactate to Support Salmonella Growth. , 2018, Cell host & microbe.

[23]  M. Heneka,et al.  Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease , 2017, Nature.

[24]  L. Facci,et al.  Expression and Differential Responsiveness of Central Nervous System Glial Cell Populations to the Acute Phase Protein Serum Amyloid A , 2017, Scientific Reports.

[25]  G. Frisoni,et al.  Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly , 2017, Neurobiology of Aging.

[26]  Jelena S. Bezbradica,et al.  Sterile signals generate weaker and delayed macrophage NLRP3 inflammasome responses relative to microbial signals , 2016, Cellular & Molecular Immunology.

[27]  G. Núñez,et al.  Nek7 is an essential mediator of NLRP3 activation downstream of potassium efflux , 2016, Nature.

[28]  D. Baker,et al.  Cellular senescence in aging and age-related disease: from mechanisms to therapy , 2015, Nature Medicine.

[29]  T. Cai,et al.  Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death , 2015, Nature.

[30]  Haitao Guo,et al.  Inflammasomes: mechanism of action, role in disease, and therapeutics , 2015, Nature Medicine.

[31]  O. Garaschuk,et al.  Neuroinflammation in Alzheimer's disease , 2015, The Lancet Neurology.

[32]  M. Heneka,et al.  Innate immunity in Alzheimer's disease , 2015, Nature Immunology.

[33]  Michael T. Heneka,et al.  Innate immune activation in neurodegenerative disease , 2014, Nature Reviews Immunology.

[34]  Vishva M. Dixit,et al.  Mechanisms and Functions of Inflammasomes , 2014, Cell.

[35]  Katherine A. Fitzgerald,et al.  Unified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes , 2014, Cell.

[36]  Zhijian J. Chen,et al.  Prion-like Polymerization Underlies Signal Transduction in Antiviral Immune Defense and Inflammasome Activation , 2014, Cell.

[37]  Abbas Ali Mahdi,et al.  Therapeutics of Alzheimer's disease: Past, present and future , 2014, Neuropharmacology.

[38]  D. Ingram,et al.  Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. , 2013, Cell metabolism.

[39]  Haitao Wen,et al.  Mechanisms of NOD-like receptor-associated inflammasome activation. , 2013, Immunity.

[40]  L. Tan,et al.  The NLRP3 Inflammasome in Alzheimer’s Disease , 2013, Molecular Neurobiology.

[41]  F. Heppner,et al.  Functional Impairment of Microglia Coincides with Beta-Amyloid Deposition in Mice with Alzheimer-Like Pathology , 2013, PloS one.

[42]  M. Heneka,et al.  NLRP3 is activated in Alzheimer´s disease and contributes to pathology in APP/PS1 mice , 2012, Nature.

[43]  Vishva M Dixit,et al.  Inflammasomes and their roles in health and disease. , 2012, Annual review of cell and developmental biology.

[44]  Richard A. Flavell,et al.  Inflammasomes in health and disease , 2012, Nature.

[45]  Debashis Sahoo,et al.  Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age , 2011, Proceedings of the National Academy of Sciences.

[46]  E. Latz,et al.  Intracellular sensing of microbes and danger signals by the inflammasomes , 2011, Immunological reviews.

[47]  J. Tschopp,et al.  A role for mitochondria in NLRP3 inflammasome activation , 2011, Nature.

[48]  Lian-tang Wang,et al.  Endogenous toll-like receptor ligands and their biological significance , 2010, Journal of cellular and molecular medicine.

[49]  C. Bryant,et al.  Molecular mechanisms involved in inflammasome activation. , 2009, Trends in cell biology.

[50]  J. Campisi,et al.  Persistent DNA damage signaling triggers senescence-associated inflammatory cytokine secretion , 2009, Nature Cell Biology.

[51]  F. Martinon,et al.  The inflammasomes: guardians of the body. , 2009, Annual review of immunology.

[52]  Weiming Xia,et al.  A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease. , 2009, Archives of neurology.

[53]  David L. Brody,et al.  Amyloid-β Dynamics Correlate with Neurological Status in the Injured Human Brain , 2008, Science.

[54]  M. Albert,et al.  Distinct pools of beta-amyloid in Alzheimer disease-affected brain: a clinicopathologic study. , 2008, Archives of neurology.

[55]  K. Moore,et al.  The NALP3 inflammasome is involved in the innate immune response to amyloid-β , 2008, Nature Immunology.

[56]  N. Weng.  Telomere and adaptive immunity , 2008, Mechanisms of Ageing and Development.

[57]  David Miller,et al.  Critical Role for Cryopyrin/Nalp3 in Activation of Caspase-1 in Response to Viral Infection and Double-stranded RNA*> , 2006, Journal of Biological Chemistry.

[58]  V. Dixit,et al.  Cryopyrin activates the inflammasome in response to toxins and ATP , 2006, Nature.

[59]  J. Julien,et al.  Bone Marrow-Derived Microglia Play a Critical Role in Restricting Senile Plaque Formation in Alzheimer's Disease , 2006, Neuron.

[60]  F. Martinon,et al.  Identification of Bacterial Muramyl Dipeptide as Activator of the NALP3/Cryopyrin Inflammasome , 2004, Current Biology.

[61]  F. Martinon,et al.  Inflammatory Caspases Linking an Intracellular Innate Immune System to Autoinflammatory Diseases , 2004, Cell.

[62]  F. Martinon,et al.  NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. , 2004, Immunity.

[63]  W. Griffin,et al.  Increased interleukin-1beta converting enzyme expression and activity in Alzheimer disease. , 1998, Journal of neuropathology and experimental neurology.

[64]  C. Gabel,et al.  Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. , 1994, The Journal of biological chemistry.

[65]  G. Perry,et al.  Microglia are associated with the extracellular neurofibrillary tangles of alzheimer disease , 1991, Brain Research.

[66]  Jun-tao Guo,et al.  Apolipoprotein Serum Amyloid A in Alzheimer's Disease. , 1999, Journal of Alzheimer's disease : JAD.